how big is the glp-1 market Drugs Size to Hit USD 132.79 Bn by 2035 How Supply and Demand for
Description
By product type, the oral GLP-1 segment is expected to grow at the fastest CAGR during the forecast period
GIP is another incretin hormone, with a similar but not identical function to GLP-1

Several real-world studies based on administrative data and pharmacy reports have demonstrated that reduced adherence to antidiabetic therapy is associated not only with poorer glycemic control but also with a significant increase in overall mortality and hospitalizations for all causes [70, 71]

That slow increase helps your body adjust and can reduce the risk of GI side effects, says Ali

But if your deficit is too aggressive (think: consistently cutting 500-plus calories a day), you increase your risk of losing muscle tissue

Looking for a B12 supplement
